Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$26.02
-0.08-0.31%
Last update: Oct 21, 6:33 PM
$25.50
-0.60-2.3%
Nurix Therapeutics Inc (NRIX) Stock Price, Quote, News & History
NRIXNASDAQ
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Nurix Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and potential commercialization of targeted protein degradation therapies for cancer and inflammatory diseases. It utilizes an integrated...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Nurix Therapeutics (NASDAQ:NRIX) through any online brokerage.
Other companies in Nurix Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Nurix Therapeutics has a consensus price target of $32.57.
The stock price for Nurix Therapeutics (NASDAQ: NRIX) is $25.5 last updated October 21, 2026 at 6:33 PM EDT.
There are no upcoming dividends for Nurix Therapeutics.
Nurix Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Nurix Therapeutics.
Nurix Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
